84 related articles for article (PubMed ID: 14614641)
1. p27 expression and proliferation in gastrointestinal stromal tumors.
Gelen MT; Elpek GO; Aksoy NH; Oğüş M; Süleymanlar I; Işitan F
Turk J Gastroenterol; 2003 Jun; 14(2):132-7. PubMed ID: 14614641
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D3 immunoreactivity in gastrointestinal stromal tumors is independent of cyclin D3 gene amplification and is associated with nuclear p27 accumulation.
Pruneri G; Mazzarol G; Fabris S; Del Curto B; Bertolini F; Neri A; Viale G
Mod Pathol; 2003 Sep; 16(9):886-92. PubMed ID: 13679452
[TBL] [Abstract][Full Text] [Related]
3. Increased cyclin D3 expression significantly correlates with p27 nuclear positivity in gastrointestinal stromal tumors.
Draper N; Bui M; Boulware DC; Lloyd M; Chiappori AA; Pledger WJ; Coppola D
Hum Pathol; 2008 Dec; 39(12):1784-91. PubMed ID: 18701138
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
Can B; Sökmensüer C
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
[TBL] [Abstract][Full Text] [Related]
5. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
6. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
Chou YP; Lin JW; Wang CC; Chiu YC; Huang CC; Chuah SK; Tai MH; Yi LN; Lee CM; Changchien CS; Hu TH
Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade.
Nakamura N; Yamamoto H; Yao T; Oda Y; Nishiyama K; Imamura M; Yamada T; Nawata H; Tsuneyoshi M
Hum Pathol; 2005 Jul; 36(7):828-37. PubMed ID: 16084954
[TBL] [Abstract][Full Text] [Related]
8. Expression of cell cycle inhibitors p21, p27, p14 and p16 in gliomas. Correlation with classic prognostic factors and patients' outcome.
Zolota V; Tsamandas AC; Aroukatos P; Panagiotopoulos V; Maraziotis T; Poulos C; Scopa CD
Neuropathology; 2008 Feb; 28(1):35-42. PubMed ID: 18181833
[TBL] [Abstract][Full Text] [Related]
9. The cyclin-dependent kinase inhibitor, p27, has no correlation with the malignant potential of GIST.
Shirin H; Kravtsov V; Shahmurov M; Shabat VS; Krinshpon I; Alin A; Avinoach I; Avni Y
Digestion; 2007; 75(1):4-9. PubMed ID: 17406118
[TBL] [Abstract][Full Text] [Related]
10. Loss of p21 expression is associated with p53 mutations and increased cell proliferation and p27 expression is associated with apoptosis in maxillary sinus squamous cell carcinoma.
Bandoh N; Hayashi T; Takahara M; Kishibe K; Ogino T; Katayama A; Imada M; Nonaka S; Harabuchi Y
Acta Otolaryngol; 2005 Jul; 125(7):779-85. PubMed ID: 16012042
[TBL] [Abstract][Full Text] [Related]
11. Elevated p21 expression is associated with poor prognosis of rectal stromal tumors after resection.
Hu TH; Tai MH; Chuah SK; Chen HH; Lin JW; Huang HY; Chou YP; Yi LN; Kuo CM; Changchien CS
J Surg Oncol; 2008 Aug; 98(2):117-23. PubMed ID: 18521824
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of cell cycle regulatory proteins in benign and malignant bone and soft tissue neoplasms.
Bui MM; Bagui TK; Boulware DC; Letson DG; Nasir A; Kaiser HE; Pledger WJ; Coppola D
In Vivo; 2007; 21(5):729-37. PubMed ID: 18019405
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancer.
Tsutsui S; Yasuda K; Suzuki K; Takeuchi H; Nishizaki T; Higashi H; Era S
BMC Cancer; 2006 Jul; 6():187. PubMed ID: 16839413
[TBL] [Abstract][Full Text] [Related]
14. Importance of proliferation markers in gastrointestinal carcinoid tumors: a clinicopathologic study.
Sökmensüer C; Gedikoglu G; Uzunalimoglu B
Hepatogastroenterology; 2001; 48(39):720-3. PubMed ID: 11462912
[TBL] [Abstract][Full Text] [Related]
15. [Roles of risk assessment and Ki-67 index in judging prognostic of gastrointestinal stromal tumors].
Liang YM; Li XH; Chen W
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1041-5. PubMed ID: 18754437
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria.
Huang HY; Huang WW; Lin CN; Eng HL; Li SH; Li CF; Lu D; Yu SC; Hsiung CY
Ann Surg Oncol; 2006 Dec; 13(12):1633-44. PubMed ID: 17013685
[TBL] [Abstract][Full Text] [Related]
17. p27 Labeling index and proliferation in gastrointestinal stromal tumors: correlations with clinicopathologic factors and recurrence.
Gelen T; Elpek GO; Aksoy NH; Ogüş M; Keleş N
Jpn J Clin Oncol; 2003 Jul; 33(7):346-52. PubMed ID: 12949061
[TBL] [Abstract][Full Text] [Related]
18. Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators.
Korkolopoulou P; Givalos N; Saetta A; Goudopoulou A; Gakiopoulou H; Thymara I; Thomas-Tsagli E; Patsouris E
Hum Pathol; 2005 Aug; 36(8):899-907. PubMed ID: 16112007
[TBL] [Abstract][Full Text] [Related]
19. Correlation of enhanced cell turnover with prognosis of gastrointestinal stromal tumors of the stomach: relevance of cellularity and p27kip1.
Nemoto Y; Mikami T; Hana K; Kikuchi S; Kobayashi N; Watanabe M; Okayasu I
Pathol Int; 2006 Dec; 56(12):724-31. PubMed ID: 17096729
[TBL] [Abstract][Full Text] [Related]
20. Significance of p53 expression in gastrointestinal stromal tumors.
Yalcinkaya U; Yerci O; Koc EU
Hepatogastroenterology; 2007; 54(73):140-3. PubMed ID: 17419248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]